The Japanese Herbal Medicine Hangeshashinto Induces Oral Keratinocyte Migration by Mediating the Expression of CXCL12 Through the Activation of Extracellular Signal-Regulated Kinase.
CXCL12
extracellular signal-regulated kinase
hangeshashinto
oral keratinocytes
oral ulcerative mucositis
Journal
Frontiers in pharmacology
ISSN: 1663-9812
Titre abrégé: Front Pharmacol
Pays: Switzerland
ID NLM: 101548923
Informations de publication
Date de publication:
2021
2021
Historique:
received:
14
04
2021
accepted:
09
12
2021
entrez:
11
2
2022
pubmed:
12
2
2022
medline:
12
2
2022
Statut:
epublish
Résumé
Several clinical studies have reported that Japanese herbal medicine Hangeshashinto (HST) has beneficial effects on chemotherapy-induced oral ulcerative mucositis (OUM). Our previous research demonstrated that HST improves chemotherapy-induced OUM through human oral keratinocyte (HOK) migration, which was suppressed by mitogen-activated protein kinase (MAPK) and C-X-C chemokine receptor 4 (CXCR4) inhibitors. However, the association between these molecules and HOK migration was unclear. Here, we examined the effects of HST on the expression of CXCR4/CXCR7 and C-X-C motif chemokine ligands 11 and 12 (CXCL11/CXCL12) in HOKs. Our results indicated that HST upregulated CXCL12, but not CXCR4, CXCR7, nor CXCL11 in HOKs. HST-induced expression of CXCL12 was significantly suppressed by an inhibitor of extracellular signal-regulated kinase (ERK), but not of p38 and c-Jun N-terminal kinase (JNK). In addition, HST induced phosphorylation of ERK in HOKs. These findings suggest that HST enhances HOK migration by upregulating CXCL12 via ERK.
Identifiants
pubmed: 35145397
doi: 10.3389/fphar.2021.695039
pii: 695039
pmc: PMC8822321
doi:
Types de publication
Journal Article
Langues
eng
Pagination
695039Informations de copyright
Copyright © 2022 Miyano, Hasegawa, Asai, Uzu, Yatsuoka, Ueno, Nonaka, Fujii and Uezono.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Integr Cancer Ther. 2014 Sep;13(5):435-45
pubmed: 24501112
Curr Pharm Des. 2012;18(31):4839-53
pubmed: 22632864
Int J Radiat Oncol Biol Phys. 2002 Mar 15;52(4):911-7
pubmed: 11958883
Arch Oral Biol. 2016 Jun;66:30-7
pubmed: 26878477
Pharmacol Res. 2017 Mar;117:288-302
pubmed: 28043879
Odontology. 2016 May;104(2):152-62
pubmed: 25649126
Oral Dis. 2010 Oct;16(7):597-600
pubmed: 20846150
Core Evid. 2010 Jun 15;4:199-205
pubmed: 20694076
Neurosci Lett. 2016 Mar 11;616:57-64
pubmed: 26827717
Oral Oncol. 1998 Jan;34(1):39-43
pubmed: 9659518
Evid Based Complement Alternat Med. 2015;2015:512947
pubmed: 26170876
J Cell Physiol. 2009 Oct;221(1):204-12
pubmed: 19496172
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000 Jul;90(1):39-47
pubmed: 10884634
Cancer Res. 2005 Nov 1;65(21):9891-8
pubmed: 16267013
Cancer. 2014 May 15;120(10):1453-61
pubmed: 24615748
Stem Cells Dev. 2013 Sep 1;22(17):2384-93
pubmed: 23544621
Mol Cancer Ther. 2007 Aug;6(8):2319-27
pubmed: 17699727
Cancer Chemother Pharmacol. 2015 Jul;76(1):97-103
pubmed: 25983022
In Vitro Cell Dev Biol Anim. 2015 Jan;51(1):92-101
pubmed: 25148824
Int J Oncol. 2018 Aug;53(2):750-760
pubmed: 29749481
Cancer. 2003 Oct 1;98(7):1531-9
pubmed: 14508842
Curr Pharm Des. 2016;22(15):2270-8
pubmed: 26891806
Semin Oncol Nurs. 2004 Feb;20(1):11-5
pubmed: 15038512
Oncol Nurs Forum. 1993 Nov-Dec;20(10):1493-502
pubmed: 8278277
J Radiat Res. 2015 Jul;56(4):669-77
pubmed: 25883171
J Natl Compr Canc Netw. 2008 Jan;6 Suppl 1:S1-21; quiz S22-4
pubmed: 18289497
Zhongguo Ying Yong Sheng Li Xue Za Zhi. 2013 Mar;29(2):142-6
pubmed: 23833969
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
Support Care Cancer. 2006 Jun;14(6):505-15
pubmed: 16601950
Mol Carcinog. 2015 Oct;54(10):1132-46
pubmed: 24962868
J Support Oncol. 2007 May;5(5):231-5
pubmed: 17564153
Head Neck. 2005 May;27(5):421-8
pubmed: 15782422
J Clin Pediatr Dent. 2007 Spring;31(3):167-70
pubmed: 17550040
Support Care Cancer. 2007 Apr;15(4):427-40
pubmed: 17131132
Cancer. 2006 Jan 15;106(2):329-36
pubmed: 16342066
Mol Cancer Ther. 2007 Nov;6(11):3039-48
pubmed: 18025287
J Biol Chem. 2002 Dec 20;277(51):49212-9
pubmed: 12370187
Methods Mol Biol. 2020;2154:1-12
pubmed: 32314203
Sci Rep. 2020 Jan 17;10(1):625
pubmed: 31953420
Radiother Oncol. 2003 Mar;66(3):253-62
pubmed: 12742264
Int J Radiat Oncol Biol Phys. 2007 Jul 15;68(4):1110-20
pubmed: 17398022
Am J Rhinol Allergy. 2009 Jul-Aug;23(4):385-91
pubmed: 19671252